Nasdaq Combined Compos (COMPX.US)

Close: 14 897.00 (+73.91), Oct 15, 2021
Positive

Low risk

Automatic technical analysis. Long term, Oct 15, 2021

Nasdaq Combined Composite Index has broken the floor of the rising trend channel in the long term, which indicates a weaker initial rising rate. The index has broken up through resistance at points 14200. This predicts a further rise. The index is assessed as technically positive for the long term.

Recommendation one to six quarters: Positive (Score: 81)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.06%0.00+0.50%
5 days0.003.33%0.00+2.18%
22 days0.008.63%0.00-1.74%
66 days0.0017.21%0.00+1.72%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Candlesticks 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Short term
Short term: Weak Negative
chart Nasdaq Combined Composite Index (COMPX) Medium term
Medium term: Weak Positive
chart Nasdaq Combined Composite Index (COMPX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK